Trademark: 97170031
Word
ISOMORPHIC LABS
Status
Pending
Status Code
730
Status Date
Friday, May 17, 2024
Serial Number
97170031
Mark Type
4
Filing Date
Monday, December 13, 2021
Published for Opposition
Tuesday, September 26, 2023

Trademark Owner History
Isomorphic Labs Limited - Owner At Publication

Classifications
9 Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development
42 Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine earning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services
"LABS"

Trademark Events
Dec 16, 2021
New Application Entered
Dec 17, 2021
New Application Office Supplied Data Entered
Sep 20, 2022
Assigned To Examiner
Sep 21, 2022
Non-Final Action Written
Sep 21, 2022
Non-Final Action E-Mailed
Sep 21, 2022
Notification Of Non-Final Action E-Mailed
Mar 21, 2023
Teas Response To Office Action Received
Mar 21, 2023
Correspondence Received In Law Office
Mar 22, 2023
Teas/Email Correspondence Entered
May 3, 2023
Assigned To Examiner
May 25, 2023
Final Refusal Written
May 25, 2023
Final Refusal E-Mailed
May 25, 2023
Notification Of Final Refusal Emailed
Aug 14, 2023
Examiners Amendment -Written
Aug 14, 2023
Examiners Amendment E-Mailed
Aug 14, 2023
Notification Of Examiners Amendment E-Mailed
Aug 14, 2023
Examiner's Amendment Entered
Aug 14, 2023
Approved For Pub - Principal Register
Aug 18, 2023
On Hold - Electronic Record Review Required
Aug 21, 2023
Electronic Record Review Complete
Sep 6, 2023
Notification Of Notice Of Publication E-Mailed
Sep 26, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 19, 2024
Teas Change Of Correspondence Received
Apr 19, 2024
Teas Change Of Owner Address Received
Sep 26, 2023
Published For Opposition
Nov 21, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 19, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
May 17, 2024
Sou Extension 1 Granted
May 17, 2024
Sou Extension 1 Filed
May 17, 2024
Sou Teas Extension Received

Trademark Alertz updated from USPTO on 2030-01-24